PeptX: Using Genetic Algorithms to optimize peptides for MHC binding

BMC Bioinformatics

Volumn 12, Issue , 2011, Pages

  Knapp, Bernhard ^a   Giczi, Verena ^a,b   Ribarics, Reiner ^a   Schreiner, Wolfgang ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Fachhochschule Campus Wien   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNE RESPONSE; BINDING AFFINITIES; HEURISTIC APPROACH; HIGH-AFFINITY BINDERS; MAJOR HISTOCOMPATIBILITY COMPLEX; PREDICTION METHODS; RECOMBINATION OPERATORS; SELECTION OPERATORS;

BINDING ENERGY; FORECASTING; GENETIC ALGORITHMS; HEURISTIC METHODS; OPTIMIZATION;

PEPTIDES;

PEPTIDE;

ALGORITHM; ANIMAL; ARTICLE; ARTIFICIAL INTELLIGENCE; CHEMISTRY; GENE; HUMAN; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; PROTEIN BINDING;

ALGORITHMS; ANIMALS; ARTIFICIAL INTELLIGENCE; GENES, MHC CLASS I; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDES; PROTEIN BINDING;

EID: 79958851553     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-241     Document Type: Article

References (56)

1. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 2006, 24:419-466.
2. Tong JC, Tan TW, Ranganathan S. Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform 2007, 8:96-108.
3. Dimitrov I, Garnev P, Flower DR, Doytchinova IA. MHC Class II Binding Prediction-A Little Help from a Friend. J Biomed Biotechnol 2010, 2010:705821.
4. Sieker F, May A, Zacharias M. Predicting affinity and specificity of antigenic peptide binding to major histocompatibility class I molecules. Curr Protein Pept Sci 2009, 10:286-296.
5. Saxova P, Buus S, Brunak S, Kesmir C. Predicting proteasomal cleavage sites: a comparison of available methods. Int Immunol 2003, 15:781-787.
6. Tong JC, Ren EC. Immunoinformatics: Current trends and future directions. Drug Discov Today 2009, 14:684-689.
7. Lafuente EM, Reche PA. Prediction of MHC-peptide binding: a systematic and comprehensive overview. Curr Pharm Des 2009, 15:3209-3220.
8. Flower DR, Macdonald IK, Ramakrishnan K, Davies MN, Doytchinova IA. Computer aided selection of candidate vaccine antigens. Immunome Res 2010, 6(Suppl 2):S1.
9. Lundegaard C, Lund O, Buus S, Nielsen M. Major histocompatibility complex class I binding predictions as a tool in epitope discovery. Immunology 2010, 130:309-318.
10. Gowthaman U, Agrewala JN. In silico tools for predicting peptides binding to HLA-class II molecules: more confusion than conclusion. J Proteome Res 2008, 7:154-163.
11. Wang P, Sidney J, Dow C, Mothe BR, Sette A, Peters B. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 2008, 4:e1000048.
12. El-Manzalawy Y, Dobbs D, Honavar V. On evaluating MHC-II binding peptide prediction methods. PLoS ONE 2008, 3:e3268.
13. Lin HH, Zhang GL, Tongchusak S, Reinherz EL, Brusic V. Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics 2008, 9(Suppl 12):S22.
14. Tsurui H, Takahashi T. Prediction of T-cell epitope. J Pharmacol Sci 2007, 105:299-316.
15. Davies MN, Sansom CE, Beazley C, Moss DS. A novel predictive technique for the MHC class II peptide-binding interaction. Mol Med 2003, 9:220-225.
16. Knapp B, Omasits U, Bohle B, Maillere B, Ebner C, Schreiner W, Jahn-Schmid B. 3-Layer-based analysis of peptide-MHC-interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model. Molecular Immunology 2009, 46:1839-1844.
17. Knapp B, Omasits U, Schreiner W, Epstein MM. A comparative approach linking molecular dynamics of altered peptide ligands and MHC with in vivo immune responses. PLoS ONE 2010, 5:e11653.
18. Davies MN, Hattotuwagama CK, Moss DS, Drew MG, Flower DR. Statistical deconvolution of enthalpic energetic contributions to MHC-peptide binding affinity. BMC Struct Biol 2006, 6:5.
19. Rognan D, Lauemoller SL, Holm A, Buus S, Tschinke V. Predicting binding affinities of protein ligands from three-dimensional models: application to peptide binding to class I major histocompatibility proteins. J Med Chem 1999, 42:4650-4658.
20. Logean A, Rognan D. Recovery of known T-cell epitopes by computational scanning of a viral genome. J Comput Aided Mol Des 2002, 16:229-243.
21. Schueler-Furman O, Altuvia Y, Sette A, Margalit H. Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci 2000, 9:1838-1846.
22. Larche M. Update on the current status of peptide immunotherapy. J Allergy Clin Immunol 2007, 119:906-909.
23. Larche M, Wraith DC. Peptide-based therapeutic vaccines for allergic and autoimmune diseases. Nat Med 2005, 11:S69-S76.
24. Larche M. Inhibition of human T-cell responses by allergen peptides. Immunology 2001, 104:377-382.
25. Mishra S, Sinha S. Immunoinformatics and modeling perspective of T cell epitope-based cancer immunotherapy: a holistic picture. J Biomol Struct Dyn 2009, 27:293-306.
26. Purcell AW, McCluskey J, Rossjohn J. More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov 2007, 6:404-414.
27. Alexander J, Fikes J, Hoffman S, Franke E, Sacci J, Appella E, Chisari FV, Guidotti LG, Chesnut RW, Livingston B, Sette A. The optimization of helper T lymphocyte (HTL) function in vaccine development. Immunol Res 1998, 18:79-92.
28. Alexander J, Sidney J, Southwood S, Ruppert J, Oseroff C, Maewal A, Snoke K, Serra HM, Kubo RT, Sette A. Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1994, 1:751-761.
29. Shang X, Wang L, Niu W, Meng G, Fu X, Ni B, Lin Z, Yang Z, Chen X, Wu Y. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues. Eur J Immunol 2009, 39:2248-2258.
30. Reche PA, Reinherz EL. PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands. Nucleic Acids Res 2005, 33:W138-W142.
31. Toussaint NC, Donnes P, Kohlbacher O. A mathematical framework for the selection of an optimal set of peptides for epitope-based vaccines. PLoS Comput Biol 2008, 4:e1000246.
32. Parker AS, Zheng W, Griswold KE, Bailey-Kellogg C. Optimization algorithms for functional deimmunization of therapeutic proteins. BMC Bioinformatics 2010, 11:180.
33. Lazar GA, Desjarlais JR, Jacinto J, Karki S, Hammond PW. A molecular immunology approach to antibody humanization and functional optimization. Mol Immunol 2007, 44:1986-1998.
34. Bhasin M, Raghava GP. Prediction of promiscuous and high-affinity mutated MHC binders. Hybrid Hybridomics 2003, 22:229-234.
35. Doytchinova IA, Walshe VA, Jones NA, Gloster SE, Borrow P, Flower DR. Coupling in silico and in vitro analysis of peptide-MHC binding: a bioinformatic approach enabling prediction of superbinding peptides and anchorless epitopes. J Immunol 2004, 172:7495-7502.
36. Walshe VA, Hattotuwagama CK, Doytchinova IA, Wong M, Macdonald IK, Mulder A, Claas FH, Pellegrino P, Turner J, Williams I, Turnbull EL, Borrow P, Flower DR. Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw 0102: a bioinformatic approach to the prediction of new epitopes. PLoS ONE 2009, 4:e8095.
37. Guan P, Doytchinova IA, Walshe VA, Borrow P, Flower DR. Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201. J Med Chem 2005, 48:7418-7425.
38. Roomp K, Antes I, Lengauer T. Predicting MHC class I epitopes in large datasets. BMC Bioinformatics 2010, 11:90.
39. Peters B, Bui HH, Frankild S, Nielson M, Lundegaard C, Kostem E, Basch D, Lamberth K, Harndahl M, Fleri W, Wilson SS, Sidney J, Lund O, Buus S, Sette A. A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol 2006, 2:e65.
40. Knapp B, Omasits U, Frantal S, Schreiner W. A critical cross-validation of high throughput structural binding prediction methods for pMHC. J Comput Aided Mol Des 2009, 23:301-307.
41. Lin HH, Ray S, Tongchusak S, Reinherz EL, Brusic V. Evaluation of MHC class I peptide binding prediction servers: applications for vaccine research. BMC Immunol 2008, 9:8.
42. Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, Bui HH, Buus S, Frankild S, Greenbaum J, Lund O, Lundegaard C, Nielsen M, Ponomarenko J, Sette A, Zhu Z, Peters B. Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 2008, 36:W513-W518.
43. Rammensee HG, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50:213-219.
44. Donnes P, Elofsson A. Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics 2002, 3:25.
45. Wan J, Liu W, Xu Q, Ren Y, Flower DR, Li T. SVRMHC prediction server for MHC-binding peptides. BMC Bioinformatics 2006, 7:463.
46. Wang R, Lai L, Wang S. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. Journal of Computer-Aided Molecular Design 2002, 16:11-26.
47. Xu J. Rapid side-chain prediction via tree decomposition. RECOMB 2005, 3500:423-439.
48. Knapp B, Omasits U, Schreiner W. Side chain substitution benchmark for peptide/MHC interaction. Protein Sci 2008, 17:977-982.
49. Baeck T. Selective Pressure in Evolutionary Algorithms: A Characterization of Selection Mechanisms. Proceedings of the First IEEE Conference on Evolutionary Computation 1994, 57-62. IEEE Press.
50. Baker JE. Reducing Bias and Inefficiency in the Selection Algorithm. New Jersey: Proceedings of the Second International Conference on Genetic Algorithms and their Application 1987, 14-21.
51. Holland JH. Adaptation in Natural and Artificial Systems. 1975, Ann Arbor: University of Michigan Press.
52. Ackley DH. A connectionist machine for genetic hillclimbing. 1987, Springer Verlag Gmbh.
53. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 1991, 351:290-296.
54. Vita R, Zarebski L, Greenbaum JA, Emami H, Hoof I, Salimi N, Damle R, Sette A, Peters B. The immune epitope database 2.0. Nucleic Acids Res 2010, 38:D854-D862.
55. Wisniewska JM, Jager N, Freier A, Losch FO, Wiesmuller KH, Walden P, Wrede P, Schneider G, Hiss JA. MHC I stabilizing potential of computer-designed octapeptides. J Biomed Biotechnol 2010, 2010:396847.
56. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res 2004, 14:1188-1190.